509 related articles for article (PubMed ID: 26142957)
1. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
Jeon KI; Phipps RP; Sime PJ; Huxlin KR
Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.
Jeon KI; Phipps RP; Sime PJ; Huxlin KR
Am J Pathol; 2017 Aug; 187(8):1660-1669. PubMed ID: 28606794
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.
Jeon KI; Kulkarni A; Woeller CF; Phipps RP; Sime PJ; Hindman HB; Huxlin KR
Am J Pathol; 2014 May; 184(5):1429-45. PubMed ID: 24650561
[TBL] [Abstract][Full Text] [Related]
4. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
Nuwormegbe SA; Sohn JH; Kim SW
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1, in association with the increased expression of connective tissue growth factor, induce the hypertrophy of the ligamentum flavum through the p38 MAPK pathway.
Cao YL; Duan Y; Zhu LX; Zhan YN; Min SX; Jin AM
Int J Mol Med; 2016 Aug; 38(2):391-8. PubMed ID: 27279555
[TBL] [Abstract][Full Text] [Related]
6. Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring.
Kuriyan AE; Lehmann GM; Kulkarni AA; Woeller CF; Feldon SE; Hindman HB; Sime PJ; Huxlin KR; Phipps RP
Exp Eye Res; 2012 Jan; 94(1):136-45. PubMed ID: 22178289
[TBL] [Abstract][Full Text] [Related]
7. JNK and p38 Inhibitors Prevent Transforming Growth Factor-β1-Induced Myofibroblast Transdifferentiation in Human Graves' Orbital Fibroblasts.
Hou TY; Wu SB; Kau HC; Tsai CC
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799469
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
[TBL] [Abstract][Full Text] [Related]
9. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787
[TBL] [Abstract][Full Text] [Related]
10. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
Wang WM; Liu F; Chen N
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism underlying the inhibitory effects of peroxisome proliferator-activated receptor γ agonists on transforming growth factor β1 in adult skin fibroblasts].
Yang CZ; Zhang HT; Wang GS; Zhou HQ; Ma C; Hu DH
Zhonghua Shao Shang Za Zhi; 2010 Dec; 26(6):448-51. PubMed ID: 21223655
[TBL] [Abstract][Full Text] [Related]
12. Activation of JNK signaling mediates connective tissue growth factor expression and scar formation in corneal wound healing.
Shi L; Chang Y; Yang Y; Zhang Y; Yu FS; Wu X
PLoS One; 2012; 7(2):e32128. PubMed ID: 22363806
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.
Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435
[TBL] [Abstract][Full Text] [Related]
14. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells.
Suk FM; Chen CH; Lin SY; Cheng CJ; Yen SJ; Hung LF; Liu DZ; Liang YC
Toxicol Lett; 2009 May; 187(1):22-7. PubMed ID: 19429239
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
16. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.
Utsugi M; Dobashi K; Ishizuka T; Masubuchi K; Shimizu Y; Nakazawa T; Mori M
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):754-61. PubMed ID: 12760970
[TBL] [Abstract][Full Text] [Related]
17. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
[TBL] [Abstract][Full Text] [Related]
18. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells.
Liu Y; Dai B; Xu C; Fu L; Hua Z; Mei C
PLoS One; 2011; 6(12):e28915. PubMed ID: 22174924
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway.
Lin CH; Yu MC; Tung WH; Chen TT; Yu CC; Weng CM; Tsai YJ; Bai KJ; Hong CY; Chien MH; Chen BC
Biochim Biophys Acta; 2013 Dec; 1833(12):2823-2833. PubMed ID: 23906792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
